My watch list  

Triple reuptake inhibitors

Triple reuptake inhibitors (TRIs) are a relatively new class of antidepressants which are currently undergoing clinical trials for treatment of depression, anxiety disorders and some personality disorders.

Additional recommended knowledge

TRIs target all three of the brain's major neurotransmitters: serotonin, dopamine and noradrenaline.

See also

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Triple_reuptake_inhibitors". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE